Chemothermia was founded in 2010 by Prof Bulent Berkada and Asst Prof Mehmet Salih Iyikesici, two experienced medical oncologists in Turkey, with the aim of delivering cancer treatment using the latest integrative approaches.

Chemothermia develops personalised protocols for each patient, integrating both genetic and metabolic approaches to the condition to improve treatment outcomes.

Treatment protocols use conventional therapeutics alongside supportive approaches to maximise their efficacy by targeting the metabolic weaknesses present in cancer cells, while reducing treatment side effects.

All patients are followed with PET-CT scans as well as MRIs and other imaging techniques as necessary, with scans carried out using the latest equipment at internationally-recognised imaging centres and reviewed by leading experts in the field.

The team at Chemothermia have published a number of papers sharing details of treatment protocols and results and continue to actively research and integrate the latest developments in the field.

While the vast majority of patients are stage IV, enquiries at all stages after diagnosis are welcome, and for all types of cancer.

Metabolically Supported Chemotherapy, Hyperthermia (Local & Whole Body), Hyperbaric Oxygen Therapy, Special Infusion Treatments, Photo-Pharmaceutical Supplements, Oncological Diet